Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)

Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical genitourinary cancer 2016-04, Vol.14 (2), p.e153-e159
Hauptverfasser: Bamias, Aristotle, Peroukidis, Stavros, Stamatopoulou, Sophia, Tzannis, Kimon, Koutsoukos, Konstantinos, Andreadis, Charalambos, Bozionelou, Vasiliki, Pistalmatzian, Nikos, Papatsoris, Athanasios, Stravodimos, Konstantinos, Varthalitis, Ioannis, Karamouzis, Michalis, Milaki, Georgia, Agorastos, Antonios, Kentepozidis, Nikos, Androulakis, Nikos, Bompolaki, Iliada, Kalofonos, Haralampos, Mavroudis, Dimitrios, Dimopoulos, Meletios A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e159
container_issue 2
container_start_page e153
container_title Clinical genitourinary cancer
container_volume 14
creator Bamias, Aristotle
Peroukidis, Stavros
Stamatopoulou, Sophia
Tzannis, Kimon
Koutsoukos, Konstantinos
Andreadis, Charalambos
Bozionelou, Vasiliki
Pistalmatzian, Nikos
Papatsoris, Athanasios
Stravodimos, Konstantinos
Varthalitis, Ioannis
Karamouzis, Michalis
Milaki, Georgia
Agorastos, Antonios
Kentepozidis, Nikos
Androulakis, Nikos
Bompolaki, Iliada
Kalofonos, Haralampos
Mavroudis, Dimitrios
Dimopoulos, Meletios A
description Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.
doi_str_mv 10.1016/j.clgc.2015.09.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1772143805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1558767315002505</els_id><sourcerecordid>1772143805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</originalsourceid><addsrcrecordid>eNp9UsuO1DAQjBCIXRZ-gAPycTkktPM2QiuNIsggrYTEMGfLcdqsByce7GSk8Cl8LQ4zcODAxY9WddlV1VH0kkJCgZZvDok0X2WSAi0SYAkAexRdU5bVMZR1-jici6KOq7LKrqJn3h8A8oJW8DS6Sss8qxiw6-jnftJG_xCTtiOxiuwWP-GgJWkecLDTAzpxXIgeyaY_iVFiT_ZuLRstDGnWintLNuQzTs76I8pJn5A01hjRWSd-33bT3C-kW0hoI1s0BsfA34Z1srPTo3DLhYm0zs5Hcrtt9037-nn0RAnj8cVlv4n2H95_abbx_af2Y7O5j2VO6RTnRQldX0vWqTxXsq-LTmW1UErRuqiQ5iizkgUrOlUzBZApBp2ss2CXqliVZzfR7Zn36Oz3Gf3EB-1l-KcY0c6e06pKaZ7VUARoeobKoNY7VPzo9BAEcAp8zYQf-JoJXzPhwHh4JDS9uvDP3YD935Y_IQTAuzMAg8qTRse91LiarV1wlPdW_5__7p92aXSwWJhvuKA_BJPH4B-n3Kcc-G6dinUoaAGQFkHVL-vktBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1772143805</pqid></control><display><type>article</type><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</creator><creatorcontrib>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</creatorcontrib><description>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</description><identifier>ISSN: 1558-7673</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2015.09.009</identifier><identifier>PMID: 26437909</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Advanced urothelial cancer ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cisplatin - therapeutic use ; Female ; Fitness for cisplatin ; Greece ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Middle Aged ; Patterns of practice ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Factors ; Survival Analysis ; Treatment Outcome ; Urologic Neoplasms - drug therapy ; Urologic Neoplasms - pathology ; Urology ; Urothelium - pathology</subject><ispartof>Clinical genitourinary cancer, 2016-04, Vol.14 (2), p.e153-e159</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</citedby><cites>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</cites><orcidid>0000-0002-1710-125X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26437909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bamias, Aristotle</creatorcontrib><creatorcontrib>Peroukidis, Stavros</creatorcontrib><creatorcontrib>Stamatopoulou, Sophia</creatorcontrib><creatorcontrib>Tzannis, Kimon</creatorcontrib><creatorcontrib>Koutsoukos, Konstantinos</creatorcontrib><creatorcontrib>Andreadis, Charalambos</creatorcontrib><creatorcontrib>Bozionelou, Vasiliki</creatorcontrib><creatorcontrib>Pistalmatzian, Nikos</creatorcontrib><creatorcontrib>Papatsoris, Athanasios</creatorcontrib><creatorcontrib>Stravodimos, Konstantinos</creatorcontrib><creatorcontrib>Varthalitis, Ioannis</creatorcontrib><creatorcontrib>Karamouzis, Michalis</creatorcontrib><creatorcontrib>Milaki, Georgia</creatorcontrib><creatorcontrib>Agorastos, Antonios</creatorcontrib><creatorcontrib>Kentepozidis, Nikos</creatorcontrib><creatorcontrib>Androulakis, Nikos</creatorcontrib><creatorcontrib>Bompolaki, Iliada</creatorcontrib><creatorcontrib>Kalofonos, Haralampos</creatorcontrib><creatorcontrib>Mavroudis, Dimitrios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios A</creatorcontrib><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><description>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</description><subject>Advanced urothelial cancer</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cisplatin - therapeutic use</subject><subject>Female</subject><subject>Fitness for cisplatin</subject><subject>Greece</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patterns of practice</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Urologic Neoplasms - drug therapy</subject><subject>Urologic Neoplasms - pathology</subject><subject>Urology</subject><subject>Urothelium - pathology</subject><issn>1558-7673</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsuO1DAQjBCIXRZ-gAPycTkktPM2QiuNIsggrYTEMGfLcdqsByce7GSk8Cl8LQ4zcODAxY9WddlV1VH0kkJCgZZvDok0X2WSAi0SYAkAexRdU5bVMZR1-jici6KOq7LKrqJn3h8A8oJW8DS6Sss8qxiw6-jnftJG_xCTtiOxiuwWP-GgJWkecLDTAzpxXIgeyaY_iVFiT_ZuLRstDGnWintLNuQzTs76I8pJn5A01hjRWSd-33bT3C-kW0hoI1s0BsfA34Z1srPTo3DLhYm0zs5Hcrtt9037-nn0RAnj8cVlv4n2H95_abbx_af2Y7O5j2VO6RTnRQldX0vWqTxXsq-LTmW1UErRuqiQ5iizkgUrOlUzBZApBp2ss2CXqliVZzfR7Zn36Oz3Gf3EB-1l-KcY0c6e06pKaZ7VUARoeobKoNY7VPzo9BAEcAp8zYQf-JoJXzPhwHh4JDS9uvDP3YD935Y_IQTAuzMAg8qTRse91LiarV1wlPdW_5__7p92aXSwWJhvuKA_BJPH4B-n3Kcc-G6dinUoaAGQFkHVL-vktBA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Bamias, Aristotle</creator><creator>Peroukidis, Stavros</creator><creator>Stamatopoulou, Sophia</creator><creator>Tzannis, Kimon</creator><creator>Koutsoukos, Konstantinos</creator><creator>Andreadis, Charalambos</creator><creator>Bozionelou, Vasiliki</creator><creator>Pistalmatzian, Nikos</creator><creator>Papatsoris, Athanasios</creator><creator>Stravodimos, Konstantinos</creator><creator>Varthalitis, Ioannis</creator><creator>Karamouzis, Michalis</creator><creator>Milaki, Georgia</creator><creator>Agorastos, Antonios</creator><creator>Kentepozidis, Nikos</creator><creator>Androulakis, Nikos</creator><creator>Bompolaki, Iliada</creator><creator>Kalofonos, Haralampos</creator><creator>Mavroudis, Dimitrios</creator><creator>Dimopoulos, Meletios A</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1710-125X</orcidid></search><sort><creationdate>20160401</creationdate><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><author>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Advanced urothelial cancer</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cisplatin - therapeutic use</topic><topic>Female</topic><topic>Fitness for cisplatin</topic><topic>Greece</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patterns of practice</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Urologic Neoplasms - drug therapy</topic><topic>Urologic Neoplasms - pathology</topic><topic>Urology</topic><topic>Urothelium - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bamias, Aristotle</creatorcontrib><creatorcontrib>Peroukidis, Stavros</creatorcontrib><creatorcontrib>Stamatopoulou, Sophia</creatorcontrib><creatorcontrib>Tzannis, Kimon</creatorcontrib><creatorcontrib>Koutsoukos, Konstantinos</creatorcontrib><creatorcontrib>Andreadis, Charalambos</creatorcontrib><creatorcontrib>Bozionelou, Vasiliki</creatorcontrib><creatorcontrib>Pistalmatzian, Nikos</creatorcontrib><creatorcontrib>Papatsoris, Athanasios</creatorcontrib><creatorcontrib>Stravodimos, Konstantinos</creatorcontrib><creatorcontrib>Varthalitis, Ioannis</creatorcontrib><creatorcontrib>Karamouzis, Michalis</creatorcontrib><creatorcontrib>Milaki, Georgia</creatorcontrib><creatorcontrib>Agorastos, Antonios</creatorcontrib><creatorcontrib>Kentepozidis, Nikos</creatorcontrib><creatorcontrib>Androulakis, Nikos</creatorcontrib><creatorcontrib>Bompolaki, Iliada</creatorcontrib><creatorcontrib>Kalofonos, Haralampos</creatorcontrib><creatorcontrib>Mavroudis, Dimitrios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bamias, Aristotle</au><au>Peroukidis, Stavros</au><au>Stamatopoulou, Sophia</au><au>Tzannis, Kimon</au><au>Koutsoukos, Konstantinos</au><au>Andreadis, Charalambos</au><au>Bozionelou, Vasiliki</au><au>Pistalmatzian, Nikos</au><au>Papatsoris, Athanasios</au><au>Stravodimos, Konstantinos</au><au>Varthalitis, Ioannis</au><au>Karamouzis, Michalis</au><au>Milaki, Georgia</au><au>Agorastos, Antonios</au><au>Kentepozidis, Nikos</au><au>Androulakis, Nikos</au><au>Bompolaki, Iliada</au><au>Kalofonos, Haralampos</au><au>Mavroudis, Dimitrios</au><au>Dimopoulos, Meletios A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>14</volume><issue>2</issue><spage>e153</spage><epage>e159</epage><pages>e153-e159</pages><issn>1558-7673</issn><eissn>1938-0682</eissn><abstract>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26437909</pmid><doi>10.1016/j.clgc.2015.09.009</doi><orcidid>https://orcid.org/0000-0002-1710-125X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1558-7673
ispartof Clinical genitourinary cancer, 2016-04, Vol.14 (2), p.e153-e159
issn 1558-7673
1938-0682
language eng
recordid cdi_proquest_miscellaneous_1772143805
source MEDLINE; Alma/SFX Local Collection
subjects Advanced urothelial cancer
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cisplatin - therapeutic use
Female
Fitness for cisplatin
Greece
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
Patterns of practice
Prognosis
Recurrence
Retrospective Studies
Risk Factors
Survival Analysis
Treatment Outcome
Urologic Neoplasms - drug therapy
Urologic Neoplasms - pathology
Urology
Urothelium - pathology
title Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20Systemic%20Chemotherapy%20in%20Advanced%20Urothelial%20Cancer:%20A%20Retrospective%20Collaborative%20Study%20by%20the%20Hellenic%20Genitourinary%20Cancer%20Group%20(HGUCG)&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Bamias,%20Aristotle&rft.date=2016-04-01&rft.volume=14&rft.issue=2&rft.spage=e153&rft.epage=e159&rft.pages=e153-e159&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2015.09.009&rft_dat=%3Cproquest_cross%3E1772143805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1772143805&rft_id=info:pmid/26437909&rft_els_id=S1558767315002505&rfr_iscdi=true